Here’s how to earn $100 in passive income by investing in Gilead Sciences stock
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.
Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and commercializes medicines to address unmet medical needs in the United States, Europe and internationally.
It will report its fourth-quarter 2024 earnings on February 11, 2025. Wall Street analysts expect the company to post earnings per share of $1.55, compared to $1.72 in the same period a year ago. According to data from Benzinga Pro, quarterly revenue is expected to reach $7.14 billion, up slightly from $7.12 billion in the same period a year ago.
Don’t miss:
Gilead Sciences’ 52-week stock price was $62.07 to $98.90.
Gilead Sciences’ dividend yield is 3.38%. Over the last twelve months, the company paid $3.08 per share in dividends.
On November 6, the company reported third-quarter 2024 earnings, with adjusted earnings per share of $2.02, compared to the consensus estimate of $1.55, and revenue of $7.54 billion, compared to the consensus of $7 billion, as reported by Benzinga.
“Gilead’s third quarter results are the strongest of the year to date, with revenue growth of 7% year-over-year, including 13% year-over-year growth for Biktarvy. Based on this very strong revenue growth and disciplined operating expense management, we are increasing our revenue, operating income and earnings per share for the full year,” said Daniel O’Day, Chairman and Chief Executive Officer of Gilead.
See also: Maker of the $60,000 foldable house has built 3 factory buildings, more than 600 homes and big plans to fix housing you can become an investor today for $0.80 per share.
The company now expects full-year product sales in the range of $27.8 billion to $28.1 billion, up from its previous guidance of $27.1 billion to $27.5 billion.
Check out this article from Benzinga, which analyzes Gilead Sciences’ short interest.
If you want to earn $100 per month – $1,200 per year – from dividends from Gilead Sciences, your investment value would need to be about $35,503, which equates to about 390 shares at $91.09 each.
Understanding Dividend Yield Calculations: When estimating, you need two important variables: the desired annual income ($1,200) and the dividend yield (in this case 3.38%). So $1,200 / 0.0338 = $35,503 to generate an income of $100 per month.
You can calculate the dividend yield by dividing the annual dividend payments by the current share price.
Trending: Commercial real estate has historically outperformed the stock market, and This platform allows individuals to invest in commercial real estate with as little as $5,000, offering a target return of 12% with a bonus 1% return increase today!
The dividend yield can change over time due to fluctuating stock prices and evolving dividend payments.
For example, suppose a stock that pays out $2 in annual dividends is worth $50. The dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in the stock price to $40 will have the opposite effect and increase the dividend yield to 5% ($2/$40).
In summary, income-oriented investors may find Gilead Sciences stock an attractive option to earn a stable income of $100 per month by owning 390 shares. There may be more upside potential as investors benefit from the company’s consistent dividend increases. Gilead Sciences has increased its dividend consecutively for the past nine years.
Wondering if your investments could earn you a $5,000,000 nest egg? Talk to a financial advisor today. SmartAsset’s free tool matches you with up to three vetted financial advisors serving your region, and you can interview your advisors for free to decide which one is right for you.
EquityMultiple’s ‘Alpine Note – Basecamp Series’ attracts attention and opens wallets. This short-term note investment offers investors a 9% yield (APY) with a term of just 3 months and a minimum of $5,000. The Basecamp rate shows a significant spread compared to government bonds. These healthy returns will not last long. With the Fed poised to cut interest rates in the near future, now could be the time to earn favorable returns with a flexible, relatively liquid investment option.
Additionally, Alpine Note – Basecamp can be merged with another Alpine Note to boost returns, or into another carefully vetted real estate investment from EquityMultiple, which also involves a minimum investment of just $5,000. Basecamp is exclusively open to new investors on the EquityMultiple platform.
Looking for fractional real estate investment opportunities? The Benzinga Real Estate Screener has the latest offering.
This article, Here’s How to Make $100 in Passive Income Investing in Gilead Sciences Stock originally appeared on Benzinga.com
